Authors:
Geoerger, B
Tang, CB
Cesano, A
Visonneau, S
Marwaha, S
Judy, KD
Sutton, LN
Santoli, D
Phillips, PC
Citation: B. Geoerger et al., Antitumor activity of a human cytotoxic T-cell line (TALL-104) in brain tumor xenografts, NEURO-ONCOL, 2(2), 2000, pp. 103-113
Authors:
Visonneau, S
Cesano, A
Porter, DL
Luger, SL
Schuchter, L
Kamoun, M
Torosian, MH
Duffy, K
Sickles, C
Stadtmauer, EA
Santoli, D
Citation: S. Visonneau et al., Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer, CLIN CANC R, 6(5), 2000, pp. 1744-1754
Citation: A. Cesano et al., Stabilization of disease as an indicator of clinical benefit associated with chemotherapy in non-small cell lung cancer patients, INT J ONCOL, 17(3), 2000, pp. 587-590
Authors:
Visonneau, S
Cesano, A
Jeglum, KA
Santoli, D
Citation: S. Visonneau et al., Adjuvant treatment of canine osteosarcoma with the human cytotoxic T-cell line TALL-104, CLIN CANC R, 5(7), 1999, pp. 1868-1875
Authors:
Visonneau, S
Cesano, A
Jeglum, KA
Santoli, D
Citation: S. Visonneau et al., Adoptive therapy of canine metastatic mammary carcinoma with the human MHCnon-restricted cytotoxic T-cell line TALL-104, ONCOL REP, 6(6), 1999, pp. 1181-1188
Authors:
Cesano, A
Lane, SR
Poulin, R
Ross, G
Fields, SZ
Citation: A. Cesano et al., Stabilization of disease as a useful predictor of survival following second-line chemotherapy in small cell lung cancer and ovarian cancer patients, INT J ONCOL, 15(6), 1999, pp. 1233-1238
Authors:
Cesano, A
Wortman, JA
Pourdehnad, M
Visonneau, S
Mozley, D
Bhatnagar, A
Alavi, A
Santoli, D
Citation: A. Cesano et al., Effects of development of host immunity on the biodistribution of xenogeneic MHC non-restricted cytotoxic T cells: Implications for adoptive cell therapy of cancer, INT J ONCOL, 14(2), 1999, pp. 233-244
Authors:
Cesano, A
Visonneau, S
Tran, T
Santoli, D
Citation: A. Cesano et al., Biodistribution of human MHC non-restricted TALL-104 killer cells in healthy and tumor bearing mice, INT J ONCOL, 14(2), 1999, pp. 245-251